QS Investors LLC Cuts Holdings in Cardinal Health, Inc. (CAH)

QS Investors LLC decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 48.9% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 22,004 shares of the company’s stock after selling 21,019 shares during the period. QS Investors LLC’s holdings in Cardinal Health were worth $1,715,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brandes Investment Partners LP bought a new stake in Cardinal Health in the 2nd quarter valued at approximately $2,464,000. Sheets Smith Wealth Management lifted its stake in Cardinal Health by 0.8% in the 2nd quarter. Sheets Smith Wealth Management now owns 36,800 shares of the company’s stock valued at $2,867,000 after acquiring an additional 300 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Cardinal Health by 202.1% in the 2nd quarter. Victory Capital Management Inc. now owns 61,304 shares of the company’s stock valued at $4,776,000 after acquiring an additional 41,013 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Cardinal Health in the 2nd quarter valued at approximately $164,000. Finally, Swiss National Bank lifted its stake in Cardinal Health by 1.6% in the 2nd quarter. Swiss National Bank now owns 1,152,648 shares of the company’s stock valued at $89,814,000 after acquiring an additional 18,600 shares in the last quarter. Hedge funds and other institutional investors own 87.98% of the company’s stock.

Shares of Cardinal Health, Inc. (NYSE:CAH) opened at 64.92 on Tuesday. The company has a market cap of $20.54 billion, a PE ratio of 16.11 and a beta of 0.86. Cardinal Health, Inc. has a 52 week low of $62.70 and a 52 week high of $84.88. The stock’s 50 day moving average price is $67.19 and its 200-day moving average price is $73.19.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. Cardinal Health’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $1.14 earnings per share. Analysts expect that Cardinal Health, Inc. will post $4.95 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a yield of 2.85%. Cardinal Health’s dividend payout ratio (DPR) is currently 45.79%.

COPYRIGHT VIOLATION WARNING: “QS Investors LLC Cuts Holdings in Cardinal Health, Inc. (CAH)” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://ledgergazette.com/2017/10/10/qs-investors-llc-cuts-holdings-in-cardinal-health-inc-cah.html.

Several equities research analysts have commented on CAH shares. Vetr upgraded Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price on the stock in a research note on Tuesday, June 13th. BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Jefferies Group LLC restated a “hold” rating and issued a $77.00 target price on shares of Cardinal Health in a research note on Thursday, July 27th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research note on Sunday, September 10th. Finally, Robert W. Baird restated a “hold” rating and issued a $73.00 target price on shares of Cardinal Health in a research note on Sunday, September 17th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. Cardinal Health presently has a consensus rating of “Hold” and a consensus price target of $76.81.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceuti

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brandes Investment Partners LP bought a new stake in Cardinal Health in the 2nd quarter valued at approximately $2,464,000. Sheets Smith Wealth Management lifted its stake in Cardinal Health by 0.8% in the 2nd quarter. Sheets Smith Wealth Management now owns 36,800 shares of the company’s stock valued at $2,867,000 after acquiring an additional 300 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Cardinal Health by 202.1% in the 2nd quarter. Victory Capital Management Inc. now owns 61,304 shares of the company’s stock valued at $4,776,000 after acquiring an additional 41,013 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Cardinal Health in the 2nd quarter valued at approximately $164,000. Finally, Swiss National Bank lifted its stake in Cardinal Health by 1.6% in the 2nd quarter. Swiss National Bank now owns 1,152,648 shares of the company’s stock valued at $89,814,000 after acquiring an additional 18,600 shares in the last quarter. Hedge funds and other institutional investors own 87.98% of the company’s stock.

Shares of Cardinal Health, Inc. (NYSE:CAH) opened at 64.92 on Tuesday. The company has a market cap of $20.54 billion, a PE ratio of 16.11 and a beta of 0.86. Cardinal Health, Inc. has a 52 week low of $62.70 and a 52 week high of $84.88. The stock’s 50 day moving average price is $67.19 and its 200-day moving average price is $73.19.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. Cardinal Health’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $1.14 earnings per share. Analysts expect that Cardinal Health, Inc. will post $4.95 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a yield of 2.85%. Cardinal Health’s dividend payout ratio (DPR) is currently 45.79%.

COPYRIGHT VIOLATION WARNING: “QS Investors LLC Cuts Holdings in Cardinal Health, Inc. (CAH)” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://ledgergazette.com/2017/10/10/qs-investors-llc-cuts-holdings-in-cardinal-health-inc-cah.html.

Several equities research analysts have commented on CAH shares. Vetr upgraded Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price on the stock in a research note on Tuesday, June 13th. BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Jefferies Group LLC restated a “hold” rating and issued a $77.00 target price on shares of Cardinal Health in a research note on Thursday, July 27th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research note on Sunday, September 10th. Finally, Robert W. Baird restated a “hold” rating and issued a $73.00 target price on shares of Cardinal Health in a research note on Sunday, September 17th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. Cardinal Health presently has a consensus rating of “Hold” and a consensus price target of $76.81.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply